Hospital to Home Transition for Childhood Asthma
(H2H Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to better support children with asthma after hospital discharge. It examines whether an "asthma navigator" can help families manage asthma care more effectively than standard support. Participants will receive either standard care or additional guidance through the Hospital to Home Transition (H2H) program, addressing asthma challenges at home and school over a year. Families with children aged 4-12 who have been hospitalized for asthma, reside in the DC, Maryland, or Virginia area, and speak English or Spanish may be eligible to join. As an unphased trial, this study offers families the chance to contribute to innovative asthma care strategies that could enhance daily life for children with asthma.
Do I need to stop my child's current medications for this asthma trial?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators for specific guidance.
What prior data suggests that this Hospital to Home Transition is safe for children with asthma?
A previous study showed that the Hospital to Home Transition (H2H) program is both practical and well-received, meaning it was easy to implement and appreciated by patients and families. Importantly, no reports of serious side effects emerged from the program.
The main feature of the H2H program is the use of asthma navigators. These trained professionals help families manage asthma care after leaving the hospital. They work closely with doctors, schools, and families to ensure children follow their asthma action plans.
Since the study is labeled "Not Applicable" for a specific phase, it likely focuses on testing the program's approach rather than a new drug. This suggests the intervention centers on coordinating care, which tends to be safer as it involves guidance rather than new medications.
Overall, the H2H program appears well-tolerated, with no major safety concerns identified so far. This could reassure families considering participation in the trial.12345Why are researchers excited about this trial?
Researchers are excited about the Hospital to Home Transition (H2H) program for childhood asthma because it offers a personalized, hands-on approach that goes beyond the typical standard of care. Most current treatments focus on medication and in-hospital care, but H2H provides a multi-component support system that includes an asthma navigator. This navigator helps families manage asthma care at home and maintains communication with primary care doctors and school nurses. By addressing challenges in the child's daily environment, this approach aims to reduce hospital readmissions and improve overall asthma management for children.
What evidence suggests that the Hospital to Home Transition (H2H) intervention is effective for childhood asthma?
Research has shown that the Hospital to Home Transition (H2H) program, which participants in this trial may receive, can assist children with asthma after hospital discharge. Early studies indicate that initiating detailed care planning while a child is still hospitalized is feasible and appreciated by families. This approach aims to enhance children's healthcare use and asthma management at home, potentially reducing emergency visits and hospital readmissions. Evidence also suggests that home monitoring of asthma, a component of the H2H program, can cut emergency visits and hospital stays by about half. This improvement means children could manage their asthma better and enjoy a higher quality of life.13678
Who Is on the Research Team?
Kavita Parikh, MD MSHS
Principal Investigator
Children's National Research Institute
Are You a Good Fit for This Trial?
This trial is for English or Spanish-speaking caregivers living in DC, Maryland, or Virginia with a child aged 4-12 hospitalized due to asthma. Caregivers must be at least 18 years old.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Data Collection
Baseline data will be collected from caregivers during the child's hospital admission for asthma exacerbation
Intervention
Intervention arm receives standard of care plus asthma navigator support post-discharge
Control
Control arm receives standard of care post-discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hospital to Home Transition (H2H)
Trial Overview
The study tests a 'Hospital to Home' (H2H) program where after hospital discharge, one group gets standard care while the other also receives support from an asthma navigator. Participants are randomly assigned to these groups.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The intervention for this study is a multi-component navigation-supported intervention for children hospitalized with asthma. Navigators will work with families for 12-months post-discharge. Trained asthma educator/navigators will work to address challenges with asthma care after discharge; will include maximum 15 contacts/12 months. The asthma navigators within this study will attempt to maintain direct contact with participants primary care doctors through email, fax, and/or postal mail as means for delivering asthma action plans, prescription updates, and patient appointment scheduling. The asthma navigators for intervention participants will attempt to maintain contact with the school nurse in efforts to have a line of communication with the school. Asthma navigators will assist families in all home-based needs pertaining to their child's asthma.
Control arm will receive the standard of care (SOC) after hospital discharge.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kavita Parikh
Lead Sponsor
Published Research Related to This Trial
Citations
Outcomes from a pilot patient-centered hospital-to-home ...
Conclusion: These pilot data suggest that comprehensive care coordination initiated during the inpatient stay is feasible and acceptable. A larger trial is ...
2.
researchgate.net
researchgate.net/publication/342959579_Outcomes_from_a_Pilot_Patient-Centered_Hospital-to-Home_Transition_Program_for_Children_Hospitalized_with_AsthmaOutcomes from a Pilot Patient-Centered Hospital-to-Home ...
Primary outcomes included feasibility and acceptability. Secondary outcomes included healthcare utilization, asthma morbidity, and caregiver quality of life.
Care transition interventions for children with asthma in the ...
This review summarizes the evidence regarding care transition interventions originating in the ED for children with uncontrolled asthma.
4.
publications.aap.org
publications.aap.org/pediatrics/article/136/6/e1602/33889/Improving-Pediatric-Asthma-Care-and-OutcomesImproving Pediatric Asthma Care and Outcomes Across ...
Overall, improved asthma outcomes occurred without any increase in hospital resource use and no change in PICU transfer or death. At community ...
Children with asthma who use at-home monitoring are half ...
Children with asthma who use at-home monitoring are around half as likely to visit the emergency department or be hospitalised, ...
Hospital to Home Transition for Childhood Asthma (H2H Trial)
The H2H medical study, being run by Kavita Parikh, is evaluating whether Hospital to Home Transition (H2H) will have tolerable side effects & efficacy for ...
Managing the Health of Children with Asthma from ... - PolicyLab
Prior research has shown that only 60% to 75% of children with persistent asthma fill a prescription for controller medications over an entire year and the ...
8.
publications.aap.org
publications.aap.org/pediatrics/article/136/6/e1539/33897/The-Family-Perspective-on-Hospital-to-HomeThe Family Perspective on Hospital to Home Transitions
Hospital-level compliance with asthma care quality measures at children's hospitals and subsequent asthma-related outcomes. JAMA . 2011.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.